Literature DB >> 25483547

Viral etiology of mumps-like illnesses in suspected mumps cases reported in Catalonia, Spain.

Irene Barrabeig1, Josep Costa, Ariadna Rovira, M Angeles Marcos, Ricard Isanta, Rubén López-Adalid, Ana Cervilla, Nuria Torner, Angela Domínguez.   

Abstract

We investigated the etiology of reported sporadic suspected mumps cases with a negative RT-PCR result for the mumps virus in the Barcelona-South region in 2007-2011. Samples from mumps virus-negative patients presenting unilateral or bilateral parotitis or other salivary gland swelling were tested for Epstein-Barr virus (EBV) by real-time PCR and for respiratory viruses by two multiplex-PCR-based assays to detect parainfluenza virus (PIV) 1-4, influenza virus (InV) A, B and C, respiratory syncytial virus (RSV), enterovirus, coronavirus 229E, coronavirus OC43, and rhinovirus. 101 samples were analyzed in persons aged 8 months to 50 years. Oral samples were collected on the first day of glandular swelling in 53 patients (52.5%), and on the first two days in 74 patients (73.3%). Viruses were detected in 52 (51.5%) of samples: one virus (25 EBV, 8 PIV3, 4 adenovirus, 4 PIV2, 1 PIV1, 1 InVA, and 1 enterovirus) was detected in 44 patients (84.6%), two viruses in 7 patients, and three viruses in one patient. In 58 patients (57.5%) whose sample was collected in the first 2 days after onset of parotitis and had received two doses of MMR vaccine and in 15 patients (14.8%) whose sample was collected on the first day, it is very likely that the cause was not the mumps virus. This would mean that 72.3% (73/101) of the reported sporadic suspected mumps cases were not mumps cases. The timing of oral-sample collection is crucial to correctly interpret the negative results for mumps virus RNA, especially when suspected cases occur in vaccinated persons.

Entities:  

Keywords:  MMR vaccine; laboratory diagnosis; mumps virus; parotitis; sample collection timing; suspected cases

Mesh:

Year:  2014        PMID: 25483547      PMCID: PMC4514168          DOI: 10.4161/hv.36165

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  26 in total

1.  Mumps outbreak in the Republic of Moldova, 2007-2008.

Authors:  Norbert G Schwarz; Helen Bernard; Anatolie Melnic; Victoria Bucov; Natalia Caterinciuc; Matthias an der Heiden; Nick Andrews; Richard Pebody; Chinara Aidyralieva; Susan Hahné
Journal:  Pediatr Infect Dis J       Date:  2010-08       Impact factor: 2.129

2.  Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students--Iowa, 2006.

Authors:  Mona Marin; Patricia Quinlisk; Tom Shimabukuro; Charu Sawhney; Cedric Brown; Charles W Lebaron
Journal:  Vaccine       Date:  2008-05-19       Impact factor: 3.641

3.  Serological study of the epidemiology of mumps virus infection in north-west England.

Authors:  D J Nokes; J Wright; P Morgan-Capner; R M Anderson
Journal:  Epidemiol Infect       Date:  1990-08       Impact factor: 2.451

4.  Etiology of mumps-like illnesses in children and adolescents vaccinated for measles, mumps, and rubella.

Authors:  Irja Davidkin; Sari Jokinen; Anja Paananen; Pauli Leinikki; Heikki Peltola
Journal:  J Infect Dis       Date:  2005-01-19       Impact factor: 5.226

5.  Comparison of the sensitivity of laboratory diagnostic methods from a well-characterized outbreak of mumps in New York city in 2009.

Authors:  Jennifer S Rota; Jennifer B Rosen; Margaret K Doll; Rebecca J McNall; Marcia McGrew; Nobia Williams; Elena N Lopareva; Albert E Barskey; Amado Punsalang; Paul A Rota; William R Oleszko; Carole J Hickman; Christopher M Zimmerman; William J Bellini
Journal:  Clin Vaccine Immunol       Date:  2013-01-16

6.  Waning antibody levels and avidity: implications for MMR vaccine-induced protection.

Authors:  Mia Kontio; Sari Jokinen; Mikko Paunio; Heikki Peltola; Irja Davidkin
Journal:  J Infect Dis       Date:  2012-09-10       Impact factor: 5.226

7.  Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Huong Q McLean; Amy Parker Fiebelkorn; Jonathan L Temte; Gregory S Wallace
Journal:  MMWR Recomm Rep       Date:  2013-06-14

Review 8.  Measles, mumps, and rubella in Finland: 25 years of a nationwide elimination programme.

Authors:  Heikki Peltola; Sari Jokinen; Mikko Paunio; Tapani Hovi; Irja Davidkin
Journal:  Lancet Infect Dis       Date:  2008-12       Impact factor: 25.071

9.  Seroepidemiology of mumps in Europe (1996-2008): why do outbreaks occur in highly vaccinated populations?

Authors:  J Eriksen; I Davidkin; G Kafatos; N Andrews; C Barbara; D Cohen; A Duks; A Griskevicius; K Johansen; K Bartha; B Kriz; G Mitis; J Mossong; A Nardone; D O'Flanagan; F DE Ory; A Pistol; H Theeten; K Prosenc; M Slacikova; R Pebody
Journal:  Epidemiol Infect       Date:  2012-06-12       Impact factor: 4.434

10.  Simultaneous detection of fourteen respiratory viruses in clinical specimens by two multiplex reverse transcription nested-PCR assays.

Authors:  M T Coiras; J C Aguilar; M L García; I Casas; P Pérez-Breña
Journal:  J Med Virol       Date:  2004-03       Impact factor: 2.327

View more
  7 in total

1.  Challenges in Interpretation of Diagnostic Test Results in a Mumps Outbreak in a Highly Vaccinated Population.

Authors:  L A Trotz-Williams; N J Mercer; K Paphitis; J M Walters; D Wallace; E Kristjanson; J Gubbay; T Mazzulli
Journal:  Clin Vaccine Immunol       Date:  2017-02-06

2.  Non-mumps Viral Parotitis During the 2014-2015 Influenza Season in the United States.

Authors:  Lina I Elbadawi; Pamela Talley; Melissa A Rolfes; Alexander J Millman; Erik Reisdorf; Natalie A Kramer; John R Barnes; Lenee Blanton; Jaime Christensen; Stefanie Cole; Tonya Danz; John J Dreisig; Rebecca Garten; Thomas Haupt; Beth M Isaac; Mary Anne Jackson; Anna Kocharian; Daniel Leifer; Karen Martin; Lisa McHugh; Rebecca J McNall; Jennifer Palm; Kay W Radford; Sara Robinson; Jennifer B Rosen; Senthilkumar K Sakthivel; Peter Shult; Anna K Strain; George Turabelidze; Lori A Webber; Meghan Pearce Weinberg; David E Wentworth; Brett L Whitaker; Lyn Finelli; Michael A Jhung; Ruth Lynfield; Jeffrey P Davis
Journal:  Clin Infect Dis       Date:  2018-08-01       Impact factor: 9.079

3.  Influenza-Associated Parotitis During the 2014-2015 Influenza Season in the United States.

Authors:  Melissa A Rolfes; Alexander J Millman; Pamela Talley; Lina I Elbadawi; Natalie A Kramer; John R Barnes; Lenee Blanton; Jeffrey P Davis; Stefanie Cole; John J Dreisig; Rebecca Garten; Thomas Haupt; Mary Anne Jackson; Anna Kocharian; Daniel Leifer; Ruth Lynfield; Karen Martin; Lisa McHugh; Sara Robinson; George Turabelidze; Lori A Webber; Meghan Pearce Weinberg; David E Wentworth; Lyn Finelli; Michael A Jhung
Journal:  Clin Infect Dis       Date:  2018-08-01       Impact factor: 9.079

4.  Mumps: MMR vaccination and genetic diversity of mumps virus, 2007-2011 in Catalonia, Spain.

Authors:  Irene Barrabeig; Andrés Antón; Núria Torner; Tomàs Pumarola; Josep Costa; Àngela Domínguez
Journal:  BMC Infect Dis       Date:  2019-11-09       Impact factor: 3.090

5.  Clinical features and origin of cases of parotiditis in an emergency department.

Authors:  Aina Scatti-Regàs; Marta Carmen Aguilar-Ferrer; Andrés Antón-Pagarolas; Xavier Martínez-Gómez; Sebastià González-Peris
Journal:  An Pediatr (Engl Ed)       Date:  2020-07-19

6.  [Clinical features and origin of cases of parotiditis in an emergency department].

Authors:  Aina Scatti-Regàs; Marta Carmen Aguilar-Ferrer; Andrés Antón-Pagarolas; Xavier Martínez-Gómez; Sebastià González-Peris
Journal:  An Pediatr (Engl Ed)       Date:  2019-12-26

7.  Influenza-Related Parotitis during a Large Mumps Outbreak - Arkansas, 2016-2017.

Authors:  Sarah M Labuda; Cheng Yang; Carol Daniels; Susan R Young; Haytham Safi; Dirk Haselow
Journal:  Arch Clin Case Rep       Date:  2019-05-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.